Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
588 INR | -1.12% | -2.28% | -9.13% |
Apr. 26 | India's SBI Life Insurance reports lower new business margin for FY 2024 | RE |
Apr. 23 | India's ICICI Prudential reports narrower new business margin for FY 2024 | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 62% by 2026.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- Low profitability weakens the company.
- With an expected P/E ratio at 83.06 and 68.36 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.13% | 15.35B | B- | ||
+3.05% | 93.95B | B | ||
+1.78% | 93.15B | B- | ||
+18.68% | 74.75B | D+ | ||
-20.65% | 73.73B | B+ | ||
+6.69% | 29.69B | B | ||
+18.06% | 28.26B | B | ||
+4.32% | 26.51B | A | ||
-1.21% | 17.36B | C+ | ||
+20.70% | 12.69B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HDFCLIFE Stock
- HDFCLIFE Stock
- Ratings HDFC Life Insurance Company Limited